http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112725434-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686 |
| filingDate | 2021-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112725434-B |
| titleOfInvention | Molecular marker, detection reagent and application of rifampicin-resistant tuberculosis |
| abstract | The invention provides a rifampicin-resistant tuberculosis molecular marker, detection reagent and application thereof. Involved in the field of biomedical technology. The molecular markers include TRIM9, TRIM21 and TRIM56 genes and their expression products; the TRIM9, TRIM21 and TRIM56 genes are down-regulated in rifampicin-resistant tuberculosis patients. The invention can identify rifampicin-resistant tuberculosis patients more quickly, efficiently and sensitively, and can be used for screening rifampicin-resistant tuberculosis. |
| priorityDate | 2021-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.